Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Film Explores Antidepressant Use in Japan (Japan)

This article was originally published in PharmAsia News

Executive Summary

A new documentary by Mike Mills called "Does Your Soul Have a Cold?" explores the use of antidepressants in Japan by following the lives of five Japanese men and women who use these pharmaceuticals for treating symptoms of clinical depression. Mills has found that Japanese society has increased its acceptance of mental illness and mental illness treatment during the last decade or so. He attributes this partially to the increase of advertising by pharmaceutical companies about mental illness. Antidepressant sales have risen by 500 percent since 1999, reports IMS. The film finds that only two out of the five depressed also seek counseling besides pharmaceutical therapy. Experts attribute this lack of counseling to Japan's lingering unease with depression. (Click here for more

You may also be interested in...



Investors Go Beserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel